Browse the full management transaction log of Savaria Corporation, a publicly traded company based in Canada. Shares are quoted on CA CA, under the authority of SEDI. Operating in the Healthcare & Pharma sector, Savaria Corporation has published 6 public disclosures. Market capitalisation: €1.6bn. The latest transaction was reported on 16 May 2026 — 10 - Acquisition or disposition in the public market. Among the most active insiders: Drutz, Peter Allen. Every trade is accessible without an account.
6 of 6 declarations
Savaria Corporation (TSX/TSXV: SIS) is a Canadian company listed on the Toronto Stock Exchange, focused on accessibility and mobility solutions. Headquartered in Laval, Quebec, Canada, Savaria designs, manufactures and sells a broad portfolio of products for private homes, healthcare facilities, and certain public spaces. The company is positioned as a global niche leader, with structural demand supported by aging demographics, the desire to age in place, and rising accessibility requirements across buildings and care environments. ([corp.savaria.com](https://corp.savaria.com/?lang=en&utm_source=openai)) Founded in 1979, Savaria was acquired in 1989 by Marcel Bourassa, now Executive Chairman, who helped transform a small local business into an international platform. Over time, the company expanded through a selective acquisition strategy that added specialist brands and capabilities in residential and commercial elevators, lifting platforms, stairlifts, patient lifts, and long-term care products. This history has shaped Savaria into a more diversified industrial healthcare-accessibility group rather than a single-product manufacturer. ([savaria.com](https://www.savaria.com/our-company?lang=en&utm_source=openai)) Savaria operates through two reportable segments: Accessibility and Patient Care. Accessibility includes home elevators, commercial lifts, stairlifts, wheelchair lifts, vehicle conversion solutions, and related mobility equipment. Patient Care covers medical beds, therapeutic surfaces, and other care-focused products. The company supports these businesses with an international manufacturing and distribution footprint, with production and operations across North America, Europe, and Asia, allowing it to serve local markets while tailoring offerings to regional requirements. ([corp.savaria.com](https://corp.savaria.com/?lang=en&utm_source=openai)) From a competitive standpoint, Savaria benefits from one of the broader product ranges in the sector, an established dealer network, and a reputation for reliability and product quality. Its scale gives it exposure to both residential and institutional end markets, while its geographically distributed facilities help reduce customer lead times and support localized engineering and customization. In a fragmented market, this combination of breadth, brand recognition, and manufacturing flexibility is an important competitive advantage. ([corp.savaria.com](https://corp.savaria.com/?lang=en&utm_source=openai)) Recent developments indicate continued operational momentum. In 2025, Savaria reported record full-year 2024 results, followed by improved second-quarter 2025 results, with growth led by Accessibility and supported by an acquisition completed during the quarter. In March 2026, the company reported fiscal 2025 annual revenue of C$913.5 million and stronger adjusted EBITDA trends, and in September 2025 it increased its monthly dividend. For investors, Savaria combines exposure to a resilient long-term healthcare-accessibility theme with recurring cash-return discipline and ongoing operational execution. ([savaria.com](https://www.savaria.com/our-company/investors?node=Q2-2025-results&utm_source=openai))